Hidetoshi Nitta

2.8k total citations
133 papers, 2.2k citations indexed

About

Hidetoshi Nitta is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Hidetoshi Nitta has authored 133 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Hepatology, 60 papers in Surgery and 45 papers in Oncology. Recurrent topics in Hidetoshi Nitta's work include Hepatocellular Carcinoma Treatment and Prognosis (55 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers) and Liver Disease Diagnosis and Treatment (27 papers). Hidetoshi Nitta is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (55 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers) and Liver Disease Diagnosis and Treatment (27 papers). Hidetoshi Nitta collaborates with scholars based in Japan, France and United States. Hidetoshi Nitta's co-authors include Toru Beppu, Hiromitsu Hayashi, Akira Chikamoto, Daisuke Hashimoto, Katsunori Imai, Hirohisa Okabe, Hideo Baba, Shigeki Nakagawa, Hideo Baba and Takaaki Higashi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Hidetoshi Nitta

125 papers receiving 2.2k citations

Peers

Hidetoshi Nitta
Yasunobu Matsuda Japan
Mitsuteru Natsuizaka Japan
Kazuyoshi Ohkawa Japan
Jonathan Fawcett Australia
Takatoshi Ishiko Japan
Purva Gopal United States
Matthew M. Yeh United States
Tianqiang Song China
Naoki Oishi Japan
Masahiro Ohira Japan
Yasunobu Matsuda Japan
Hidetoshi Nitta
Citations per year, relative to Hidetoshi Nitta Hidetoshi Nitta (= 1×) peers Yasunobu Matsuda

Countries citing papers authored by Hidetoshi Nitta

Since Specialization
Citations

This map shows the geographic impact of Hidetoshi Nitta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetoshi Nitta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetoshi Nitta more than expected).

Fields of papers citing papers by Hidetoshi Nitta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetoshi Nitta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetoshi Nitta. The network helps show where Hidetoshi Nitta may publish in the future.

Co-authorship network of co-authors of Hidetoshi Nitta

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetoshi Nitta. A scholar is included among the top collaborators of Hidetoshi Nitta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetoshi Nitta. Hidetoshi Nitta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okabe, Hirohisa, Hidetoshi Nitta, Daisuke Kuroda, et al.. (2024). Advanced Cholangiocarcinoma With High Tumor Mutation Burden Achieving Complete Response to Immune Check Point Inhibitor. Anticancer Research. 44(7). 3199–3203. 2 indexed citations
2.
Ogawa, Daisuke, Tatsunori Miyata, Takashi Matsumoto, et al.. (2024). Prognostic value of preoperative geriatric nutritional risk index in intrahepatic cholangiocarcinoma after hepatectomy: a single‑center retrospective cohort study. Langenbeck s Archives of Surgery. 409(1). 47–47.
3.
4.
Yamamura, Kensuke, Toru Beppu, Tatsunori Miyata, et al.. (2021). Conversion Surgery for Hepatocellular Carcinoma Following Molecular Therapy. Anticancer Research. 42(1). 35–44. 7 indexed citations
5.
Nitta, Hidetoshi, Kazuto Harada, Kenji Shimizu, et al.. (2021). How to treat remnant cholecystitis after subtotal cholecystectomy: two case reports. SHILAP Revista de lepidopterología. 7(1). 109–109. 2 indexed citations
6.
Miyata, Tatsunori, Hiromitsu Hayashi, Yo‐ichi Yamashita, et al.. (2021). The Impact of Histologic Liver Inflammation on Oncology and the Prognosis of Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Annals of Surgical Oncology. 29(2). 893–902. 4 indexed citations
7.
Nitta, Hidetoshi, Takayuki Shimose, Yasunori Emi, et al.. (2016). Expression of the anaphylatoxin C5a receptor in gastric cancer: implications for vascular invasion and patient outcomes. Medical Oncology. 33(11). 118–118. 20 indexed citations
8.
Nitta, Hidetoshi, Shigeki Nakagawa, Takayoshi Kaida, et al.. (2016). Pre-treatment double- or triple-positive tumor markers are predictive of a poor outcome for patients undergoing radiofrequency ablation for hepatocellular carcinoma. Surgery Today. 47(3). 375–384. 11 indexed citations
9.
Hashimoto, Daisuke, Kota Arima, Naomi Yokoyama, et al.. (2016). Heterogeneity of KRAS Mutations in Pancreatic Ductal Adenocarcinoma. Pancreas. 45(8). 1111–1114. 32 indexed citations
10.
Hayashi, Hiromitsu, Takaaki Higashi, Naomi Yokoyama, et al.. (2015). An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression. Cancer Research. 75(22). 4985–4997. 121 indexed citations
11.
Arima, Kota, Hirohisa Okabe, Daisuke Hashimoto, et al.. (2015). The Neutrophil-to-Lymphocyte Ratio Predicts Malignant Potential in Intraductal Papillary Mucinous Neoplasms. Journal of Gastrointestinal Surgery. 19(12). 2171–2177. 36 indexed citations
12.
Nitta, Hidetoshi, Yoji Murakami, Yoshihiro Wada, et al.. (2014). Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness. Oncology Reports. 32(4). 1715–1719. 54 indexed citations
13.
Nitta, Hidetoshi, Yoshihiro Wada, Yoshiaki Kawano, et al.. (2013). Enhancement of Human Cancer Cell Motility and Invasiveness by Anaphylatoxin C5a via Aberrantly Expressed C5a Receptor (CD88). Clinical Cancer Research. 19(8). 2004–2013. 84 indexed citations
14.
Nakagawa, Shigeki, Hirohisa Okabe, Yasuo Sakamoto, et al.. (2013). Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis. Annals of Surgical Oncology. 20(S3). 667–675. 52 indexed citations
15.
Ikuta, Yoshiaki, Hiroshi Takamori, Yasuo Sakamoto, et al.. (2013). The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers. International Journal of Clinical Oncology. 19(4). 629–633. 14 indexed citations
16.
Okabe, Hirohisa, Takatsugu Ishimoto, Kosuke Mima, et al.. (2013). CD44s signals the acquisition of the mesenchymal phenotype required for anchorage-independent cell survival in hepatocellular carcinoma. British Journal of Cancer. 110(4). 958–966. 57 indexed citations
17.
Nitta, Hidetoshi, Takahisa Imamura, Yoshihiro Wada, et al.. (2008). Production of C5a by ASP, a Serine Protease Released from Aeromonas sobria. The Journal of Immunology. 181(5). 3602–3608. 20 indexed citations
18.
Imamura, Takahisa, Hidetomo Kobayashi, Rasel Khan, Hidetoshi Nitta, & Keinosuke Okamoto. (2006). Induction of Vascular Leakage and Blood Pressure Lowering through Kinin Release by a Serine Proteinase from Aeromonas sobria. The Journal of Immunology. 177(12). 8723–8729. 30 indexed citations
19.
Nitta, Hidetoshi, et al.. (2005). A Case of Superior Mesenteric Venous Thrombosis Successfully Treated in Two-Stage Operation. The Japanese Journal of Gastroenterological Surgery. 38(10). 1602–1606. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasunobu Matsuda Breakdown of academic impact, for papers by Mitsuteru Natsuizaka Breakdown of academic impact, for papers by Kazuyoshi Ohkawa Breakdown of academic impact, for papers by Jonathan Fawcett Breakdown of academic impact, for papers by Takatoshi Ishiko Breakdown of academic impact, for papers by Purva Gopal Breakdown of academic impact, for papers by Matthew M. Yeh Breakdown of academic impact, for papers by Tianqiang Song Breakdown of academic impact, for papers by Naoki Oishi Breakdown of academic impact, for papers by Masahiro Ohira
Rankless by CCL
2026